According to the latest report published by Data Bridge Market Research, the Immuno-Oncology Clinical Trials Market  CAGR Value Data Bridge Market Research analyses that the immuno-oncology clinical trials market to account growing at a CAGR of 13.70% in the forecast period of 2022 to 2029. In this persuasive Immuno-Oncology Clinical Trials Market report, market...

 According to the latest report published by Data Bridge Market Research, the Oncology Imaging Software Market  CAGR Value The global Oncology Imaging Software Market size was valued at USD 4.44 billion in 2025 and is expected to reach USD 6.80 billion by 2033, at a CAGR of 5.5% during the forecast period The Oncology Imaging Software...

 According to the latest report published by Data Bridge Market Research, the Oncology Information Systems Market  CAGR Value Global Oncology Information Systems Market is increasing at a CAGR of 7.90%. Our detailed analysis forecasts that the market is valued at USD 4.30 billion in 2023 and is expected to grow upto USD 7.91 billion by 2031. This Oncology Information...

(R)-N-Boc-3-(Aminomethyl)Pyrrolidine market was valued at USD 28.4 million in 2025 and is projected to reach USD 58.2 million by 2034, exhibiting a remarkable CAGR of 7.4% during the forecast period.  (R)-N-Boc-3-(Aminomethyl)Pyrrolidine is a specialized chiral pyrrolidine derivative featuring a tert-butoxycarbonyl (Boc) protecting group and an aminomethyl substituent at the 3-position....

  As we move through 2026, the oncology landscape is witnessing a transformative era, with pembrolizumab continuing to set the benchmark for cancer care. The Keytruda Market analysis reveals that the drug’s ability to treat over 40 indications—ranging from non-small cell lung cancer to advanced melanoma—has solidified its position as a global blockbuster. In 2026, the...

Polaris Market Research today announced findings from its latest report, projecting the global AI in Oncology market to grow from USD 6.51 billion in 2025 to USD 56.44 billion by 2034, at a CAGR of 27.1%. The report profiles 10 leading companies across multiple market segments, benchmarking the global AI in oncology landscape across component, application, and regional lines. The market covers...

AI In Oncology Market Overview The AI in oncology market was valued at USD 6.0 billion in 2025. It is estimated at USD 8.3 billion in 2026 and is projected to reach USD 38.9 billion by 2033, a CAGR of 24.8% from 2026 to 2033. That is roughly a 4.7x expansion in seven years, and it signals that AI is becoming a core layer of cancer care rather than an experimental add-on. North America led in...

Cancer diagnosis used to hinge almost entirely on the trained eye of a radiologist or pathologist, working scan by scan, slide by slide. That model is now being layered — not replaced, but sharpened — by algorithms that can flag a suspicious lesion in milliseconds or predict a chemotherapy dose from a CT scan's fat, bone, and muscle composition. That shift is exactly what's fueling...

"Executive Summary Anthracycline-Based Oncology Drug Class Market Size and Share Forecast CAGR Value Anthracycline-Based Oncology Drug Class Market research report brings into focus the key market dynamics of the sector. The Anthracycline-Based Oncology Drug Class Market study also analyzes the market status, market share, growth rate, future trends, market drivers, opportunities, challenges,...

The Anti-Neoplastic Agents Market is undergoing significant transformation as pharmaceutical innovation, advances in oncology, and increasing cancer prevalence drive demand for effective therapeutic solutions. Anti-neoplastic agents encompass medicines used to prevent, inhibit, or control the growth and spread of cancer cells. The evolving oncology landscape is encouraging pharmaceutical...

The global industry was valued at US$ 140.2 Bn in 2022 and is estimated to grow at a CAGR of 9.1% from 2023 to 2031, reaching US$ 303.1 Bn by the end of 2031. The anticancer drugs market is witnessing substantial expansion as the global burden of cancer continues to rise and healthcare systems increasingly prioritize advanced oncology treatments. The growing prevalence of various forms of...

The oncology landscape is undergoing a radical transformation as immunotherapy moves to the forefront of cancer care. By late 2025 and heading into 2026, the focus has shifted from general applications to highly personalized treatment protocols. These inhibitors, which unmask cancer cells to the body’s natural defense systems, are now being utilized not just as last-resort measures but as...

The cancer biomarkers market is entering a period of strong expansion as rising cancer cases, increasing emphasis on early diagnosis, and growing adoption of personalized treatment continue to reshape oncology care. According to Grand View Research, the market size was valued at USD 26.9 billion in 2025 and is projected to increase from USD 29.9 billion in 2026 to USD 65.3 billion by 2033,...

The AI in oncology market is entering a rapid expansion phase as healthcare providers, researchers, and pharmaceutical companies increasingly use artificial intelligence to improve cancer diagnostics, treatment planning, and research. The market was valued at USD 6.0 billion in 2025 and is projected to grow from USD 8.3 billion in 2026 to USD 38.9 billion by 2033, registering a CAGR of 24.8%...

Chemotherapy at Home Services Market: Growth, Trends, Demand & Forecast to 2034 Chemotherapy at Home Services Market Snapshot The Chemotherapy at Home Services Market is emerging as an important segment of decentralized cancer care, supported by the growing demand for convenient treatment options, advances in home healthcare infrastructure, and increasing interest in...

  As we move through 2026, the global fight against cancer has entered a phase of unprecedented acceleration. The Oncology Drugs Market Growth Dynamics are currently defined by a "precision-first" approach, where the traditional boundaries between chemotherapy and immunotherapy are blurring. Market valuation is now surging toward the $210 billion mark, fueled by the rapid clinical...

"First-in-Class Oncology Drug Market Summary: According to the latest report published by Data Bridge Market Research, the First-in-Class Oncology Drug Market The global first-in-class oncology drug market size was valued at USD 8.67 billion in 2025 and is expected to reach USD 25.08 billion by 2033, at a CAGR of14.20% during the forecast periodThe market growth is largely fueled by...

Demand Outlook for Executive Summary Hormone-Refractory Oncology Drug Market Market Size and Share CAGR Value The global hormone-refractory oncology drug market size was valued at USD 5.33 billion in 2025 and is expected to reach USD 12.46 billion by 2033, at a CAGR of 11.20% during the forecast period The wide-ranging report deals with the new business challenges and investment...

Executive Summary Tumor Ablation Market Research: Share and Size Intelligence CAGR Value The global tumor ablation market size was valued at USD 1.94 billion in 2024 and is expected to reach USD 5.47 billion by 2032, at a CAGR of 13.8% during the forecast period This Tumor Ablation Market research report is a painstaking investigation of current scenario of the market and future...

Polaris Market Research releases its new research report on the Immuno-Oncology (IO) market, which provides comprehensive insight into the current market landscape and future outlook. It discusses all the major forces that can help drive growth in the market. This report studies the effect of rising demand, technology, applications, investments, and competition. It offers a comprehensive...